Legis Daily

Further Continuing Appropriations Act, 2021, and Other Extensions Act

USA116th CongressHR-8900| House 
| Updated: 12/11/2020
Nita M. Lowey

Nita M. Lowey

Democratic Representative

New York

Appropriations Committee, Budget Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Further Continuing Appropriations Act, 2021, and Other Extensions Act This bill provides continuing FY2021 appropriations to federal agencies through December 18, 2020, and extends several expiring health programs. DIVISION A--FURTHER CONTINUING APPROPRIATIONS ACT, 2021 Further Continuing Appropriations Act, 2021 This division provides continuing FY2021 appropriations to federal agencies through December 18, 2020. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2021 appropriations bills have not been enacted when the existing CR expires on December 11, 2020. DIVISION B--HEALTH EXTENDERS TITLE I--MEDICARE AND MEDICAID EXTENDERS (Sec. 1101) This section extends certain minimum adjustments to the work geographic index with respect to the payment of physician services under Medicare. (Sec. 1102) This section extends funding for state health insurance programs, area agencies on aging, aging and disability resource centers, and technical assistance related to outreach and enrollment with respect to Medicare and other programs. (Sec. 1103) This section extends funding for certain Medicare quality-measurement activities. (Sec. 1104) This section extends the Medicaid demonstration program for certified community behavioral health clinics. (Sec. 1105) This section extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 1106) This section delays certain reductions to Medicaid disproportionate-share hospital allotments. (Sec. 1107) This section extends the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services (CMS) may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.) TITLE II--PUBLIC HEALTH EXTENDERS AND FOOD AND DRUG ADMINISTRATION PROVISIONS Subtitle A--Public Health Extenders (Sec. 1201) This section extends funding for specified programs for community health centers; teaching health centers that operate graduate medical education programs; and the National Health Service Corps, which provides scholarships and student loan repayment programs for health care workers. (Sec. 1202) This section extends funding for research grants to prevent and cure Type I diabetes and grants for services to prevent and treat diabetes among Native Americans. (Sec. 1203) This section extends funding for certain grants for states to educate adolescents on the prevention of pregnancy and sexually transmitted infections. Subtitle B--Food and Drug Administration Provisions (Sec. 1211) This section extends the authority of the Food and Drug Administration to designate a rare pediatric disease drug application as eligible for a priority review voucher. TITLE III--OFFSETS (Sec. 1301) This section requires the CMS to share Medicare Advantage (MA) and Medicare prescription drug benefit enrollment information with liability insurers in response to Medicare secondary payer inquiries. Specifically, the CMS must share whether the claimant who is the subject of the inquiry was entitled to Medicare benefits during the preceding three-year period on any basis, and must also share the plan name and address of any MA or prescription drug benefit plan in which the claimant was enrolled. (Sec. 1302) This section requires the Drug Enforcement Administration (DEA) to revise regulations that allow a practitioner to administer narcotic drugs to a person for purposes of relieving acute withdrawal symptoms while the person awaits arrangements for narcotic treatment. The regulations currently authorize up to a one-day supply of narcotic drugs at one time, for a total of up to three days. The DEA must revise these regulations so as to allow a practitioner to dispense up to a three-day supply of narcotic drugs to one person or for one person's use at one time for the purpose of initiating maintenance treatment or detoxification treatment, or both. (Sec. 1303) This section increases the funds available to the Medicaid Improvement Fund for state activities relating to mechanized claims systems beginning in FY2025. TITLE IV--BUDGETARY EFFECTS (Sec. 1401) This section exempts the budgetary effects of this division from (1) the Statutory Pay-As-You-Go Act of 2010 (PAYGO), (2) the Senate PAYGO rule, and (3) certain budget scorekeeping rules.

Bill Text Versions

View Text
5 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 8, 2020
Introduced in House
Dec 8, 2020
Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 9, 2020
Received in the Senate, read twice.
Dec 9, 2020
Ms. DeLauro moved to suspend the rules and pass the bill.
Dec 9, 2020
Considered under suspension of the rules. (consideration: CR H7062-7066)
Dec 9, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 8900.
Dec 9, 2020
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 9, 2020
Considered as unfinished business. (consideration: CR H7092-7093)
Dec 9, 2020
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 343 - 67 (Roll no. 240). (text: CR H7062-7064)
View Vote
Dec 9, 2020
Motion to reconsider laid on the table Agreed to without objection.
Dec 11, 2020
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S7443-7444)
Dec 11, 2020
Passed Senate without amendment by Voice Vote. (consideration: CR S7443-7444)
Dec 11, 2020
Message on Senate action sent to the House.
Dec 11, 2020
Presented to President.
Dec 11, 2020
Signed by President.
Dec 11, 2020
Became Public Law No: 116-215.
  • December 8, 2020
    Introduced in House


  • December 8, 2020
    Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 9, 2020
    Received in the Senate, read twice.


  • December 9, 2020
    Ms. DeLauro moved to suspend the rules and pass the bill.


  • December 9, 2020
    Considered under suspension of the rules. (consideration: CR H7062-7066)


  • December 9, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 8900.


  • December 9, 2020
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • December 9, 2020
    Considered as unfinished business. (consideration: CR H7092-7093)


  • December 9, 2020
    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 343 - 67 (Roll no. 240). (text: CR H7062-7064)
    View Vote


  • December 9, 2020
    Motion to reconsider laid on the table Agreed to without objection.


  • December 11, 2020
    Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S7443-7444)


  • December 11, 2020
    Passed Senate without amendment by Voice Vote. (consideration: CR S7443-7444)


  • December 11, 2020
    Message on Senate action sent to the House.


  • December 11, 2020
    Presented to President.


  • December 11, 2020
    Signed by President.


  • December 11, 2020
    Became Public Law No: 116-215.

Economics and Public Finance

Related Bills

  • HR 116-1375: PAID Act
  • S 116-1989: PAID Act
  • HR 116-8337: Continuing Appropriations Act, 2021 and Other Extensions Act
  • HR 116-2281: Easy MAT for Opioid Addiction Act
Administrative law and regulatory proceduresAgingAppropriationsChild healthDepartment of Health and Human ServicesDepartment of JusticeDigestive and metabolic diseasesDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesEducation programs fundingExecutive agency funding and structureFood and Drug Administration (FDA)Health care coverage and accessHealth care qualityHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHospital careIndian social and development programsMarriage and family statusMedicaidMedical educationMedicareMental healthMinority healthPrescription drugsSex and reproductive health

Further Continuing Appropriations Act, 2021, and Other Extensions Act

USA116th CongressHR-8900| House 
| Updated: 12/11/2020
Further Continuing Appropriations Act, 2021, and Other Extensions Act This bill provides continuing FY2021 appropriations to federal agencies through December 18, 2020, and extends several expiring health programs. DIVISION A--FURTHER CONTINUING APPROPRIATIONS ACT, 2021 Further Continuing Appropriations Act, 2021 This division provides continuing FY2021 appropriations to federal agencies through December 18, 2020. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2021 appropriations bills have not been enacted when the existing CR expires on December 11, 2020. DIVISION B--HEALTH EXTENDERS TITLE I--MEDICARE AND MEDICAID EXTENDERS (Sec. 1101) This section extends certain minimum adjustments to the work geographic index with respect to the payment of physician services under Medicare. (Sec. 1102) This section extends funding for state health insurance programs, area agencies on aging, aging and disability resource centers, and technical assistance related to outreach and enrollment with respect to Medicare and other programs. (Sec. 1103) This section extends funding for certain Medicare quality-measurement activities. (Sec. 1104) This section extends the Medicaid demonstration program for certified community behavioral health clinics. (Sec. 1105) This section extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 1106) This section delays certain reductions to Medicaid disproportionate-share hospital allotments. (Sec. 1107) This section extends the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services (CMS) may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.) TITLE II--PUBLIC HEALTH EXTENDERS AND FOOD AND DRUG ADMINISTRATION PROVISIONS Subtitle A--Public Health Extenders (Sec. 1201) This section extends funding for specified programs for community health centers; teaching health centers that operate graduate medical education programs; and the National Health Service Corps, which provides scholarships and student loan repayment programs for health care workers. (Sec. 1202) This section extends funding for research grants to prevent and cure Type I diabetes and grants for services to prevent and treat diabetes among Native Americans. (Sec. 1203) This section extends funding for certain grants for states to educate adolescents on the prevention of pregnancy and sexually transmitted infections. Subtitle B--Food and Drug Administration Provisions (Sec. 1211) This section extends the authority of the Food and Drug Administration to designate a rare pediatric disease drug application as eligible for a priority review voucher. TITLE III--OFFSETS (Sec. 1301) This section requires the CMS to share Medicare Advantage (MA) and Medicare prescription drug benefit enrollment information with liability insurers in response to Medicare secondary payer inquiries. Specifically, the CMS must share whether the claimant who is the subject of the inquiry was entitled to Medicare benefits during the preceding three-year period on any basis, and must also share the plan name and address of any MA or prescription drug benefit plan in which the claimant was enrolled. (Sec. 1302) This section requires the Drug Enforcement Administration (DEA) to revise regulations that allow a practitioner to administer narcotic drugs to a person for purposes of relieving acute withdrawal symptoms while the person awaits arrangements for narcotic treatment. The regulations currently authorize up to a one-day supply of narcotic drugs at one time, for a total of up to three days. The DEA must revise these regulations so as to allow a practitioner to dispense up to a three-day supply of narcotic drugs to one person or for one person's use at one time for the purpose of initiating maintenance treatment or detoxification treatment, or both. (Sec. 1303) This section increases the funds available to the Medicaid Improvement Fund for state activities relating to mechanized claims systems beginning in FY2025. TITLE IV--BUDGETARY EFFECTS (Sec. 1401) This section exempts the budgetary effects of this division from (1) the Statutory Pay-As-You-Go Act of 2010 (PAYGO), (2) the Senate PAYGO rule, and (3) certain budget scorekeeping rules.

Bill Text Versions

View Text
5 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 8, 2020
Introduced in House
Dec 8, 2020
Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 9, 2020
Received in the Senate, read twice.
Dec 9, 2020
Ms. DeLauro moved to suspend the rules and pass the bill.
Dec 9, 2020
Considered under suspension of the rules. (consideration: CR H7062-7066)
Dec 9, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 8900.
Dec 9, 2020
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 9, 2020
Considered as unfinished business. (consideration: CR H7092-7093)
Dec 9, 2020
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 343 - 67 (Roll no. 240). (text: CR H7062-7064)
View Vote
Dec 9, 2020
Motion to reconsider laid on the table Agreed to without objection.
Dec 11, 2020
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S7443-7444)
Dec 11, 2020
Passed Senate without amendment by Voice Vote. (consideration: CR S7443-7444)
Dec 11, 2020
Message on Senate action sent to the House.
Dec 11, 2020
Presented to President.
Dec 11, 2020
Signed by President.
Dec 11, 2020
Became Public Law No: 116-215.
  • December 8, 2020
    Introduced in House


  • December 8, 2020
    Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 9, 2020
    Received in the Senate, read twice.


  • December 9, 2020
    Ms. DeLauro moved to suspend the rules and pass the bill.


  • December 9, 2020
    Considered under suspension of the rules. (consideration: CR H7062-7066)


  • December 9, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 8900.


  • December 9, 2020
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • December 9, 2020
    Considered as unfinished business. (consideration: CR H7092-7093)


  • December 9, 2020
    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 343 - 67 (Roll no. 240). (text: CR H7062-7064)
    View Vote


  • December 9, 2020
    Motion to reconsider laid on the table Agreed to without objection.


  • December 11, 2020
    Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S7443-7444)


  • December 11, 2020
    Passed Senate without amendment by Voice Vote. (consideration: CR S7443-7444)


  • December 11, 2020
    Message on Senate action sent to the House.


  • December 11, 2020
    Presented to President.


  • December 11, 2020
    Signed by President.


  • December 11, 2020
    Became Public Law No: 116-215.
Nita M. Lowey

Nita M. Lowey

Democratic Representative

New York

Appropriations Committee, Budget Committee

Economics and Public Finance

Related Bills

  • HR 116-1375: PAID Act
  • S 116-1989: PAID Act
  • HR 116-8337: Continuing Appropriations Act, 2021 and Other Extensions Act
  • HR 116-2281: Easy MAT for Opioid Addiction Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAgingAppropriationsChild healthDepartment of Health and Human ServicesDepartment of JusticeDigestive and metabolic diseasesDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesEducation programs fundingExecutive agency funding and structureFood and Drug Administration (FDA)Health care coverage and accessHealth care qualityHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHospital careIndian social and development programsMarriage and family statusMedicaidMedical educationMedicareMental healthMinority healthPrescription drugsSex and reproductive health